# Ceva Inc: Form 10-Q for the period ended Mar 31, 2020

- Company: [Ceva Inc](/companies/ceva.md) (CIK 1173489)
- Form: 10-Q
- Filed: 2020-05-11
- Accepted by EDGAR: May 11, 2020, 16:10 ET
- Period: 2020-03-31
- Accession: 0001437749-20-010290
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1173489/000143774920010290/ceva20200331_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1173489/000143774920010290/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-01-01 to 2020-03-31 | $23.6m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months, 2020-01-01 to 2020-03-31 | $2.8m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2020-01-01 to 2020-03-31 | $20.9m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-01-01 to 2020-03-31 | $15.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2020-01-01 to 2020-03-31 | −$1.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2020-01-01 to 2020-03-31 | $353.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-01-01 to 2020-03-31 | −$1.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-01-01 to 2020-03-31 | −$0.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-01-01 to 2020-03-31 | −$0.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-01-01 to 2020-03-31 | 22,421,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2020-01-01 to 2020-03-31 | $6.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-01-01 to 2020-03-31 | $790.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2020-01-01 to 2020-03-31 | $4.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-03-31 | $22.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-03-31 | $181.2m | us-gaap:AssetsCurrent |
| Total assets | at 2020-03-31 | $295.9m | us-gaap:Assets |
| Current liabilities | at 2020-03-31 | $27.6m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2020-03-31 | $249.3m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1173489/000143774920010290/ceva20200331_10q.htm

Filed May 11, 2020.
Source: SEC EDGAR, the filing index for accession 0001437749-20-010290. Last ingested by Listed: Nov 14, 2026, 23:48 ET. No prices; not investment advice.
